Product NDC: | 0469-8234 |
Proprietary Name: | Adenocard |
Non Proprietary Name: | adenosine |
Active Ingredient(s): | 3 mg/mL & nbsp; adenosine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0469-8234 |
Labeler Name: | Astellas Pharma US, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019937 |
Marketing Category: | NDA |
Start Marketing Date: | 19891030 |
Package NDC: | 0469-8234-12 |
Package Description: | 10 SYRINGE, PLASTIC in 1 PACKAGE (0469-8234-12) > 2 mL in 1 SYRINGE, PLASTIC |
NDC Code | 0469-8234-12 |
Proprietary Name | Adenocard |
Package Description | 10 SYRINGE, PLASTIC in 1 PACKAGE (0469-8234-12) > 2 mL in 1 SYRINGE, PLASTIC |
Product NDC | 0469-8234 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | adenosine |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19891030 |
Marketing Category Name | NDA |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | ADENOSINE |
Strength Number | 3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |